Name | 3-bromo-2-hydroxy-5-phenylbenzoic acid |
---|---|
Synonyms |
5-Brom-4-hydroxy-biphenyl-3-carbonsaeure
5-bromo-4-hydroxy-biphenyl-3-carboxylic acid [1,1'-Biphenyl]-3-carboxylic acid, 3'-bromo-4-hydroxy- 3-bromo-5-phenylsalicylic acid 3-Bromo-5-phenylsalicylc acid 5-Bromo-4-hydroxy-3-biphenylcarboxylic acid 3'-Bromo-4-hydroxy-3-biphenylcarboxylic acid [1,1'-biphenyl]-3-carboxylic acid,5-bromo-4-hydroxy [1,1'-Biphenyl]-3-carboxylic acid, 5-bromo-4-hydroxy- |
Description | AKR1C1-IN-1 is a potent and selective inhibitor of human 20α-hydroxysteroid dehydrogenase (AKR1C1), with a Ki value of 4 nM for AKR1C1[1]. |
---|---|
Related Catalog | |
Target |
Ki: 4 nM (AKR1C1), 87 nM (AKR1C2), 4.2 μM (AKR1C3), 18.2 μM (AKR1C4)[1] |
In Vitro | AKR1C1-IN-1 potently inhibits the metabolism of progesterone in AKR1C1-overexpressed BAECs, and with an IC50 of 460 nM[1]. |
References |
Density | 1.6±0.0 g/cm3 |
---|---|
Boiling Point | 439.2±0.0 °C at 760 mmHg |
Molecular Formula | C13H9BrO3 |
Molecular Weight | 293.113 |
Flash Point | 219.4±0.0 °C |
Exact Mass | 291.974000 |
PSA | 57.53000 |
LogP | 4.43 |
Vapour Pressure | 0.0±0.0 mmHg at 25°C |
Index of Refraction | 1.663 |
~% 4906-68-7 |
Literature: Dow Chem. Co. Patent: US2779785 , 1952 ; |
Precursor 1 | |
---|---|
DownStream 0 |